NO904569L - Benzimidazolderivater og fremgangsmaate for deres fremstilling. - Google Patents
Benzimidazolderivater og fremgangsmaate for deres fremstilling.Info
- Publication number
- NO904569L NO904569L NO90904569A NO904569A NO904569L NO 904569 L NO904569 L NO 904569L NO 90904569 A NO90904569 A NO 90904569A NO 904569 A NO904569 A NO 904569A NO 904569 L NO904569 L NO 904569L
- Authority
- NO
- Norway
- Prior art keywords
- group
- procedures
- preparation
- derivatives
- benzimidazold
- Prior art date
Links
- 238000000034 method Methods 0.000 title 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 102000005862 Angiotensin II Human genes 0.000 abstract 1
- 101800000733 Angiotensin-2 Proteins 0.000 abstract 1
- 208000024172 Cardiovascular disease Diseases 0.000 abstract 1
- CZGUSIXMZVURDU-JZXHSEFVSA-N Ile(5)-angiotensin II Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C=CC=CC=1)C([O-])=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=[NH2+])NC(=O)[C@@H]([NH3+])CC([O-])=O)C(C)C)C1=CC=C(O)C=C1 CZGUSIXMZVURDU-JZXHSEFVSA-N 0.000 abstract 1
- 229950006323 angiotensin ii Drugs 0.000 abstract 1
- 150000001450 anions Chemical class 0.000 abstract 1
- 230000003042 antagnostic effect Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 150000002460 imidazoles Chemical class 0.000 abstract 1
- 229940079865 intestinal antiinfectives imidazole derivative Drugs 0.000 abstract 1
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000006850 spacer group Chemical group 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 125000000547 substituted alkyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/08—Radicals containing only hydrogen and carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/12—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6503—Five-membered rings
- C07F9/6506—Five-membered rings having the nitrogen atoms in positions 1 and 3
- C07F9/65068—Five-membered rings having the nitrogen atoms in positions 1 and 3 condensed with carbocyclic rings or carbocyclic ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Vascular Medicine (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Polyesters Or Polycarbonates (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP27738589 | 1989-10-24 | ||
| JP32897489 | 1989-12-18 | ||
| JP514790 | 1990-01-11 | ||
| JP9167590 | 1990-04-05 | ||
| JP9732490 | 1990-04-11 | ||
| JP11314590 | 1990-04-27 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| NO904569D0 NO904569D0 (no) | 1990-10-23 |
| NO904569L true NO904569L (no) | 1991-04-25 |
| NO177304B NO177304B (no) | 1995-05-15 |
| NO177304C NO177304C (no) | 1995-08-23 |
Family
ID=27547894
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO904569A NO177304C (no) | 1989-10-24 | 1990-10-23 | Analogifremgangsmåte for fremstilling av terapeutisk aktive benzimidazolderivater |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US5128356A (no) |
| EP (1) | EP0425921B1 (no) |
| JP (1) | JP3099241B2 (no) |
| AT (1) | ATE126219T1 (no) |
| AU (1) | AU649418B2 (no) |
| CA (1) | CA2028302C (no) |
| DE (1) | DE69021502T2 (no) |
| FI (1) | FI102068B (no) |
| HU (1) | HUT55384A (no) |
| IE (1) | IE67956B1 (no) |
| IL (1) | IL95975A (no) |
| NO (1) | NO177304C (no) |
| NZ (1) | NZ235762A (no) |
| PT (2) | PT95655B (no) |
Families Citing this family (77)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3928177A1 (de) * | 1989-04-08 | 1991-02-28 | Thomae Gmbh Dr K | Benzimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
| GB8911854D0 (en) * | 1989-05-23 | 1989-07-12 | Ici Plc | Heterocyclic compounds |
| IE70593B1 (en) * | 1989-09-29 | 1996-12-11 | Eisai Co Ltd | Biphenylmethane derivative the use of it and pharmacological compositions containing same |
| DK0443983T3 (da) * | 1990-02-19 | 1996-03-18 | Ciba Geigy Ag | Acrylforbindelser |
| FR2674523A1 (fr) * | 1991-03-28 | 1992-10-02 | Roussel Uclaf | Nouveaux derives de benzimidazole, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant. |
| ATE171177T1 (de) * | 1990-06-08 | 1998-10-15 | Hoechst Marion Roussel Inc | Benzimidazol-derivate, verfahren und zwischenprodukte zu ihrer herstellung, ihre anwendung als arzneimittel und diese enthaltende pharmazeutische zusammensetzungen |
| FR2670489B1 (fr) * | 1990-12-18 | 1994-10-14 | Roussel Uclaf | Nouveaux derives de benzimidazole, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant. |
| RU1836357C (ru) * | 1990-07-23 | 1993-08-23 | Др.Карл Томэ ГмбХ | Производные бензимидазола, их изомеры, смеси изомеров, гидраты или их физиологически переносимые соли, обладающие антагонистическими в отношении ангиотензина свойствами |
| DE4036706A1 (de) * | 1990-11-17 | 1992-05-21 | Hoechst Ag | Verfahren zur behandlung der cardialen sowie der vasculaeren hypertrophie und hyperplasie |
| AU657498B2 (en) * | 1990-12-14 | 1995-03-16 | Novartis Ag | Biphenylyl compounds |
| TW274551B (no) * | 1991-04-16 | 1996-04-21 | Takeda Pharm Industry Co Ltd | |
| CA2068756A1 (en) * | 1991-05-16 | 1992-11-17 | Barry C. Ross | Benzofuran derivatives |
| IL102183A (en) * | 1991-06-27 | 1999-11-30 | Takeda Chemical Industries Ltd | The heterocyclic compounds are converted into biphenyl groups, their production and the pharmaceutical compositions containing them |
| TW300219B (no) * | 1991-09-14 | 1997-03-11 | Hoechst Ag | |
| US5283242A (en) * | 1991-10-24 | 1994-02-01 | American Home Products Corporation | Substituted benzimidazoles and quinazolines as antihypertensives |
| JP2682353B2 (ja) * | 1991-11-20 | 1997-11-26 | 武田薬品工業株式会社 | 経口用医薬組成物およびその製造法 |
| TW284688B (no) * | 1991-11-20 | 1996-09-01 | Takeda Pharm Industry Co Ltd | |
| US5378701A (en) * | 1991-12-27 | 1995-01-03 | Kyowa Hakko Kogyo | Tricyclic compounds |
| EP0549352B1 (en) * | 1991-12-27 | 2000-03-01 | Kyowa Hakko Kogyo Co., Ltd. | Tricyclic compounds as angiotensin II antagonists |
| WO1993017682A1 (en) * | 1992-03-04 | 1993-09-16 | Abbott Laboratories | Angiotensin ii receptor antagonists |
| US5605919A (en) * | 1993-02-26 | 1997-02-25 | Takeda Chemical Industries, Ltd. | Treatment for viral diseases |
| CA2115985A1 (en) * | 1993-02-25 | 1994-08-26 | Kohei Nishikawa | Vascular hypertrophy suppressor |
| JP2003306432A (ja) * | 1993-04-22 | 2003-10-28 | Takeda Chem Ind Ltd | 腎疾患の予防または治療剤 |
| JP3810020B2 (ja) | 1993-04-22 | 2006-08-16 | 武田薬品工業株式会社 | 腎疾患の予防または治療剤 |
| CA2125251C (en) | 1993-06-07 | 2005-04-26 | Yoshiyuki Inada | A pharmaceutical composition for angiotensin ii-mediated diseases |
| US5721263A (en) * | 1993-06-07 | 1998-02-24 | Takeda Chemical Industries, Ltd. | Pharmaceutical composition for angiotensin II-mediated diseases |
| CZ154994A3 (en) * | 1993-07-02 | 1995-09-13 | Senju Pharma Co | Visual hypotensive agent |
| ZA945190B (en) * | 1993-07-30 | 1995-02-24 | Kotobuki Seiyaku Co Ltd | Carboxymethylidenecycloheptimidazole derivatives method or manufacturing the same and therapeutic agents containing these compounds |
| US5753672A (en) * | 1994-04-19 | 1998-05-19 | Tanabe Seiyaku Co., Ltd. | Imidazopyridine derivatives and process for preparing the same |
| AU679616B2 (en) * | 1994-04-19 | 1997-07-03 | Tanabe Seiyaku Co., Ltd. | Imidazopyridine derivatives and process for preparing the same |
| CA2150610C (en) * | 1994-06-01 | 1999-08-17 | Mikiro Yanaka | Benzene derivatives and pharmaceutical composition |
| AU677702B2 (en) * | 1994-10-13 | 1997-05-01 | Takeda Pharmaceutical Company Limited | A prophylactic or therapeutic drug for renal diseases |
| HUP9901092A3 (en) * | 1995-08-02 | 2001-11-28 | Univ Newcastle Ventures Ltd | Benzimidazole compounds and their pharmaceutical use |
| JP3166065B2 (ja) * | 1996-02-08 | 2001-05-14 | 東京エレクトロン株式会社 | 処理装置及び処理方法 |
| US6177587B1 (en) | 1997-05-26 | 2001-01-23 | Takeda Chemical Industries, Ltd. | Production method of aminobenzene compound |
| BR9908474A (pt) | 1998-03-04 | 2000-12-05 | Takeda Chemical Industries Ltd | Preparação de liberação prolongada, processo para a produção de uma preparação de liberação prolongada, e, composição farmacêutica |
| DE60037192T2 (de) | 1999-07-21 | 2008-05-15 | Takeda Pharmaceutical Co. Ltd. | Mittel zur verbesserung der erkrankungen nach zerebralen durchblutungsstörungen sowie zur verhinderung deren fortschreitens |
| SE9903028D0 (sv) | 1999-08-27 | 1999-08-27 | Astra Ab | New use |
| TWI265925B (en) | 1999-10-11 | 2006-11-11 | Pfizer | Pyrazolo[4,3-d]pyrimidin-7-ones useful in inhibiting type 5 cyclic guanosine 3',5'-monophosphate phosphodiesterases(cGMP PDE5), process and intermediates for their preparation, their uses and composition comprising them |
| EP2062593A3 (en) | 2000-12-01 | 2011-08-17 | Takeda Pharmaceutical Company Limited | Method for producing preparation containing bioactive peptide |
| CA2466659A1 (en) | 2001-11-13 | 2003-05-22 | Takeda Chemical Industries, Ltd. | Anticancer agents |
| ES2407849T3 (es) * | 2002-03-13 | 2013-06-14 | Array Biopharma, Inc. | Derivados de bencimidazol alquilados N3 como inhibidores de MEK |
| US7232828B2 (en) | 2002-08-10 | 2007-06-19 | Bethesda Pharmaceuticals, Inc. | PPAR Ligands that do not cause fluid retention, edema or congestive heart failure |
| CA2542499A1 (en) | 2003-10-16 | 2005-04-28 | Teva Pharmaceutical Industries Ltd. | Preparation of candesartan cilexetil |
| US7692023B2 (en) | 2004-02-11 | 2010-04-06 | Teva Pharmaceutical Industries Ltd. | Candesartan cilexetil polymorphs |
| EP1742938A1 (en) * | 2004-05-05 | 2007-01-17 | Teva Pharmaceutical Industries Ltd. | Preparation of candesartan cilexetil in high purity |
| DE102004060699A1 (de) * | 2004-12-16 | 2006-06-22 | Ratiopharm Gmbh | Verfahren zur Herstellung von Candesartan |
| DK1863801T3 (da) * | 2005-03-30 | 2010-11-15 | Takeda Pharmaceutical | Benzimidazolderivat og anvendelse deraf |
| EP1764365A1 (en) * | 2005-09-20 | 2007-03-21 | KRKA, D.D., Novo Mesto | A process for the preparation of sartan derivates and intermediates useful in such process |
| CN101528262A (zh) | 2006-08-10 | 2009-09-09 | 武田药品工业株式会社 | 药物组合物 |
| KR20100031113A (ko) * | 2007-05-24 | 2010-03-19 | 엘드러그 에스.에이. | 1,(3),5-치환된 이미다졸, 이의 고혈압 치료 용도 및 이의 제조 방법 |
| EP2170930B3 (en) | 2007-06-04 | 2013-10-02 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
| WO2009140111A1 (en) * | 2008-05-15 | 2009-11-19 | Merck & Co., Inc. | Angiotensin ii receptor antagonists |
| JP2011522828A (ja) | 2008-06-04 | 2011-08-04 | シナジー ファーマシューティカルズ インコーポレイテッド | 胃腸障害、炎症、癌、およびその他の障害の治療のために有用なグアニル酸シクラーゼのアゴニスト |
| AU2009270833B2 (en) | 2008-07-16 | 2015-02-19 | Bausch Health Ireland Limited | Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders |
| WO2010067912A1 (en) * | 2008-12-12 | 2010-06-17 | Pharmacostech Co., Ltd. | Methods for preparing biphenyl benzoic acid derivatives |
| US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
| WO2012047538A1 (en) | 2010-10-06 | 2012-04-12 | Glaxosmithkline Llc | Benzimidazole derivatives as pi3 kinase inhibitors |
| CN104428293B (zh) | 2012-06-11 | 2018-06-08 | Ucb生物制药私人有限公司 | 调节TNFα的苯并咪唑类 |
| WO2014151206A1 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
| CA2905435A1 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Compositions useful for the treatment of gastrointestinal disorders |
| EP2991644B1 (en) * | 2013-04-04 | 2020-03-25 | University of Maryland, Baltimore | Nonsteroidal and steroidal compounds with potent androgen receptor down-regulation and anti prostate cancer activity |
| EP3004138B1 (en) | 2013-06-05 | 2024-03-13 | Bausch Health Ireland Limited | Ultra-pure agonists of guanylate cyclase c, method of making and using same |
| US10364572B2 (en) | 2014-08-30 | 2019-07-30 | Innovative Building Technologies, Llc | Prefabricated wall panel for utility installation |
| US10260250B2 (en) | 2014-08-30 | 2019-04-16 | Innovative Building Technologies, Llc | Diaphragm to lateral support coupling in a structure |
| CZ2015687A3 (cs) | 2015-10-02 | 2017-04-12 | Zentiva, K.S. | Farmaceutická kompozice obsahující kombinaci kandesartanu, amlodipinu a hydrochlorthiazidu |
| KR102279403B1 (ko) | 2016-03-07 | 2021-07-21 | 이노베이티브 빌딩 테크놀러지스 엘엘씨 | 유틸리티 설치를 위한 미리 조립된 벽 패널 |
| JP6786617B2 (ja) | 2016-03-07 | 2020-11-18 | イノベイティブ ビルディング テクノロジーズ，エルエルシー | 外部導管係合特徴部を備えたプレハブ式間仕切り壁 |
| AU2017229471B2 (en) | 2016-03-07 | 2019-08-08 | Innovative Building Technologies, Llc | Waterproofing assemblies and prefabricated wall panels including the same |
| EP3426982A4 (en) | 2016-03-07 | 2019-10-16 | Innovative Building Technologies LLC | FLOOR AND CEILING PANEL FOR PLATE-FREE FLOOR SYSTEM OF A BUILDING |
| JP7090069B2 (ja) * | 2017-03-15 | 2022-06-23 | 住友ファーマ株式会社 | 重水素化ベンズイミダゾール化合物およびその医薬用途 |
| US11098475B2 (en) | 2017-05-12 | 2021-08-24 | Innovative Building Technologies, Llc | Building system with a diaphragm provided by pre-fabricated floor panels |
| US10323428B2 (en) | 2017-05-12 | 2019-06-18 | Innovative Building Technologies, Llc | Sequence for constructing a building from prefabricated components |
| US10724228B2 (en) | 2017-05-12 | 2020-07-28 | Innovative Building Technologies, Llc | Building assemblies and methods for constructing a building using pre-assembled floor-ceiling panels and walls |
| US10487493B2 (en) | 2017-05-12 | 2019-11-26 | Innovative Building Technologies, Llc | Building design and construction using prefabricated components |
| JP7038004B2 (ja) | 2018-05-24 | 2022-03-17 | 本田技研工業株式会社 | 光学部品の洗浄方法及び洗浄装置 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5671074A (en) * | 1979-11-12 | 1981-06-13 | Takeda Chem Ind Ltd | 1,2-disubstituted-4-halogenoimidazole-5-acetic acid derivative |
| JPS5671073A (en) * | 1979-11-12 | 1981-06-13 | Takeda Chem Ind Ltd | Imidazole derivative |
| US4612323A (en) * | 1983-06-27 | 1986-09-16 | Sumitomo Chemical Company, Limited | Insecticidal and acaricidal derivatives of 1-benzylbenzimidazole |
| JPS61151176A (ja) * | 1984-12-24 | 1986-07-09 | Sumitomo Chem Co Ltd | ベンズイミダゾール誘導体およびそれを有効成分とする殺虫、殺ダニ剤 |
| US4812462A (en) * | 1986-04-01 | 1989-03-14 | Warner-Lambert Company | 4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxylic acid analogs having antihypertensive activity |
| CA1334092C (en) * | 1986-07-11 | 1995-01-24 | David John Carini | Angiotensin ii receptor blocking imidazoles |
| US4820843A (en) * | 1987-05-22 | 1989-04-11 | E. I. Du Pont De Nemours And Company | Tetrazole intermediates to antihypertensive compounds |
| US5015651A (en) * | 1988-01-07 | 1991-05-14 | E. I. Du Pont De Nemours And Company | Treatment of hypertension with 1,2,4-angiotensin II antagonists |
| US4880804A (en) * | 1988-01-07 | 1989-11-14 | E. I. Du Pont De Nemours And Company | Angiotensin II receptor blocking benzimidazoles |
| JPH0273071A (ja) * | 1988-09-09 | 1990-03-13 | Sumitomo Chem Co Ltd | ベンズイミダゾール誘導体、その製造法およびそれを有効成分とする殺虫、殺ダニ剤 |
| DE3928177A1 (de) * | 1989-04-08 | 1991-02-28 | Thomae Gmbh Dr K | Benzimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
| CA2016710A1 (en) * | 1989-05-15 | 1990-11-15 | Prasun K. Chakravarty | Substituted benzimidazoles as angiotensin ii antagonists |
| GB8911854D0 (en) * | 1989-05-23 | 1989-07-12 | Ici Plc | Heterocyclic compounds |
| IE70593B1 (en) * | 1989-09-29 | 1996-12-11 | Eisai Co Ltd | Biphenylmethane derivative the use of it and pharmacological compositions containing same |
-
1990
- 1990-10-12 IL IL95975A patent/IL95975A/xx not_active IP Right Cessation
- 1990-10-15 AU AU64612/90A patent/AU649418B2/en not_active Ceased
- 1990-10-19 DE DE69021502T patent/DE69021502T2/de not_active Expired - Fee Related
- 1990-10-19 US US07/599,894 patent/US5128356A/en not_active Expired - Fee Related
- 1990-10-19 AT AT90120054T patent/ATE126219T1/de not_active IP Right Cessation
- 1990-10-19 NZ NZ235762A patent/NZ235762A/en unknown
- 1990-10-19 EP EP90120054A patent/EP0425921B1/en not_active Expired - Lifetime
- 1990-10-23 IE IE380390A patent/IE67956B1/en not_active IP Right Cessation
- 1990-10-23 PT PT95655A patent/PT95655B/pt not_active IP Right Cessation
- 1990-10-23 NO NO904569A patent/NO177304C/no not_active IP Right Cessation
- 1990-10-23 JP JP02286299A patent/JP3099241B2/ja not_active Expired - Fee Related
- 1990-10-23 FI FI905215A patent/FI102068B/fi not_active IP Right Cessation
- 1990-10-23 CA CA002028302A patent/CA2028302C/en not_active Expired - Fee Related
- 1990-10-24 HU HU906539A patent/HUT55384A/hu unknown
-
1996
- 1996-05-24 PT PT101875A patent/PT101875B/pt not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| NO904569D0 (no) | 1990-10-23 |
| AU649418B2 (en) | 1994-05-26 |
| US5128356A (en) | 1992-07-07 |
| NO177304C (no) | 1995-08-23 |
| PT101875B (pt) | 1999-04-30 |
| AU6461290A (en) | 1991-05-02 |
| IL95975A (en) | 1997-06-10 |
| PT95655B (pt) | 1996-09-30 |
| CA2028302A1 (en) | 1991-04-25 |
| IE903803A1 (en) | 1991-04-24 |
| IL95975A0 (en) | 1991-07-18 |
| ATE126219T1 (de) | 1995-08-15 |
| EP0425921A1 (en) | 1991-05-08 |
| EP0425921B1 (en) | 1995-08-09 |
| FI102068B1 (fi) | 1998-10-15 |
| CA2028302C (en) | 2002-01-15 |
| DE69021502T2 (de) | 1996-01-11 |
| PT95655A (pt) | 1991-09-13 |
| NZ235762A (en) | 1992-04-28 |
| JP3099241B2 (ja) | 2000-10-16 |
| FI905215A0 (fi) | 1990-10-23 |
| HU906539D0 (en) | 1991-04-29 |
| HUT55384A (en) | 1991-05-28 |
| JPH049373A (ja) | 1992-01-14 |
| FI102068B (fi) | 1998-10-15 |
| DE69021502D1 (de) | 1995-09-14 |
| PT101875A (pt) | 1997-12-31 |
| IE67956B1 (en) | 1996-05-15 |
| NO177304B (no) | 1995-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO904569L (no) | Benzimidazolderivater og fremgangsmaate for deres fremstilling. | |
| DK0629609T3 (da) | Fremgangsmåde til fremstilling af alkoxyiminoacetamidderivater og et mellemprodukt dertil | |
| NO893453D0 (no) | Antibakterielle spiro-forbindelser og fremgangsmaate for deres fremstilling. | |
| AU5117890A (en) | Trifluromethylphenylazolylmethyloxiranes, the preparation thereof and the use thereof as crop protection agents | |
| ES8700228A1 (es) | Un procedimiento para producir derivados de propargiloxiacetonitrilo sustituido. | |
| ATE93232T1 (de) | Bis(methylendioxy)biphenyl-verbindungen. | |
| ES2043807T3 (es) | Compuestos anticancer. | |
| FI852223A0 (fi) | Saosom fungicider anvaenda triazoler. | |
| ES2038710T3 (es) | Un procedimiento de preparacion de un derivado de benzoxazina y su utilizacion. | |
| ATE69605T1 (de) | Azolylpropenyl- und azolylmethyloxiran-derivate und diese enthaltende fungizide. | |
| DK23089A (da) | Thioformamidderivater og deres anvendelse | |
| FR2354326A1 (fr) | Nouveaux 3-(alkyl oxygene)-1,9-dihydroxy (ou 1-hydroxy-9-ceto)-dibenzo (b,d) pyrannes a activite analgesique | |
| ATE105565T1 (de) | Pradimicinderivate. | |
| ES2024332A6 (es) | Procedimiento para la obtencion de nuevas sulfonamidas. | |
| ES2012695A6 (es) | Un procedimiento para la preparacion de 4-(6'-metoxi -2'- naftil)-but-3-en -2-ona. | |
| DK0391673T3 (da) | Fremstilling af glutarsyrederivater | |
| ES8500937A1 (es) | Un procedimiento de preparacion de nuevos benzopirano-(2,3-d)-v-triazoles. | |
| MY104164A (en) | Heterocyclic compounds. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |
Free format text: LAPSED IN APRIL 2003 |